Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What …

2 days ago · Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know . Zacks Equity Research January 14, 2025 AMGN Quick Quote AMGN. Better trading starts here.

5%
OFF

Amgen Inc. (AMGN) Is Attracting Investor Attention: Here Is What …

2 weeks from now

Nov 29, 2024 · Amgen is expected to post earnings of $4.97 per share for the current quarter, representing a year-over-year change of +5.5%. Over the last 30 days, the Zacks Consensus …

yahoo.com

1%
OFF

Why Amgen (AMGN) Is A Top Momentum Stock For The Long-Term

2 weeks from now

2 days ago · AMGN also boasts an average earnings surprise of 4.1%. With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, AMGN should be on investors' short list.

nasdaq.com

5%
OFF

Why Amgen (AMGN) Is A Top Momentum Stock For The Long …

2 weeks from now

2 days ago · AMGN is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of B and VGM Score of B. Shares are up 4.5% over the past one week and up 1.4% over the past four …

yahoo.com

FAQs about Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What … Coupon?

Is Amgen (AMGN) a good stock to buy?

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this world's largest biotech drugmaker have returned +1.4%, compared to the Zacks S&P 500 composite's -2.2% change. ...

Does Amgen's earnings estimate change with near-term stock price movements?

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Amgen is expected to post earnings of $5.13 per share, indicating a change of +3.4% from the year-ago quarter. The Zacks Consensus Estimate has changed 0% over the last 30 days. ...

What is the consensus earnings estimate for Amgen (Amgen)?

For the current fiscal year, the consensus earnings estimate of $19.57 points to a change of +4.9% from the prior year. Over the last 30 days, this estimate has changed +0.1%. For the next fiscal year, the consensus earnings estimate of $20.36 indicates a change of +4.1% from what Amgen is expected to report a year ago. ...

Is Amgen a good biotech company?

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health and nephrology and neuroscience markets. ...

How much will Amgen (Amgen) earn in a quarter?

For the current quarter, Amgen is expected to post earnings of $5.02 per share, indicating a change of +6.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.9% over the last 30 days. For the current fiscal year, the consensus earnings estimate of $19.57 points to a change of +4.9% from the prior year. ...

How did Amgen perform in the last quarter?

Amgen reported revenues of $8.5 billion in the last reported quarter, representing a year-over-year change of +23.2%. EPS of $5.58 for the same period compares with $4.96 a year ago. Compared to the Zacks Consensus Estimate of $8.51 billion, the reported revenues represent a surprise of -0.04%. ...